These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in ovarian cancer. Brown MR; Blanchette JO; Kohn EC Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):901-18. PubMed ID: 11141340 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. Mendiola M; Barriuso J; Redondo A; Mariño-Enríquez A; Madero R; Espinosa E; Vara JA; Sánchez-Navarro I; Hernández-Cortes G; Zamora P; Pérez-Fernández E; Miguel-Martín M; Suárez A; Palacios J; González-Barón M; Hardisson D PLoS One; 2008; 3(12):e4051. PubMed ID: 19112514 [TBL] [Abstract][Full Text] [Related]
15. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray]. Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Abulafia O; Triest WE; Sherer DM Am J Obstet Gynecol; 1997 Sep; 177(3):541-7. PubMed ID: 9322621 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer. Siddiqui GK; Elmasry K; Wong Te Fong AC; Perrett C; Morris R; Crow JC; Maclean AB Eur J Gynaecol Oncol; 2010; 31(2):156-9. PubMed ID: 20527230 [TBL] [Abstract][Full Text] [Related]
20. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]